pharma.ravenconnects.com Open in urlscan Pro
63.33.194.234  Public Scan

Submitted URL: http://comms.ravenconnects.com/ls/click?upn=u001.nGFMyz9m4KzBh5KPD5-2BKEx0JyW6W19bJjdHlCeyEe3H8yEDvwbaN0DICxGlZabiuCT5m_3HnSy7T...
Effective URL: https://pharma.ravenconnects.com/
Submission: On August 19 via manual from NL — Scanned from NL

Form analysis 1 forms found in the DOM

GET /search

<form class="mb-4" method="GET" action="/search"><input name="s"
    class="focus:border-white font-thin text-[1.1rem] bg-white border-white placeholder-black max-w-full text-black md:w-[30rem] border mr-[1rem] px-[1.25rem] py-[.8rem] rounded-[0.5rem] my-[1rem] lg:my-0" type="text"
    placeholder="Search for whitepapers, topics, and case studies"> <button class="bg-main-dark font-[500] text-[1.1rem] text-white mr-[1rem] px-[1.8rem] py-[.8rem] rounded-[0.5rem]">Search</button></form>

Text Content

About Us
How it works
Contact Us



CONTENT LIBRARY FOR TODAY'S
TECHNOLOGY LEADERS

Search
Latest Content
Pharmaceutical


HOLISTIC CLINICAL DATA TRANSFORMATION: SETTING THE STAGE FOR AI-DRIVEN
PRODUCTIVITY

Read now for expert insights into:
Report Clinical Studies Pharmaceutical Research and Development


OPTIMIZING PHARMACEUTICAL TRANSPORTATION MANAGEMENT IN EUROPE

Join experts from Thermo Fisher Scientific to explore:
Webinar Clinical Studies Pharmaceutical Research and Development


WHY PARTICLES' SIZE IS IMPORTANT IN PHARMACEUTICAL INDUSTRY? IS IT REALLY
PROBLEMATIC?

The whitepaper discusses the critical role of particle size distribution in
pharmaceutical manufacturing, particularly for HPAPIs, and outlines methods for
achieving desired particle sizes.
Whitepaper Pharmaceutical


ANTIBODY-DRUG CONJUGATES: GLOBAL CLINICAL TRIAL LANDSCAPE (2024)

Don’t miss critical data and informative market analysis that examines ADC’s
current state, development trends, and future potential. This data-rich report
features:
Report Clinical Studies Pharmaceutical Research and Development


ONCOLOGY ROUNDTABLE REPORT: HOW TECH IS TRANSFORMING THE LANDSCAPE

Expert panellists address the key trends and challenges shaping the future of
oncology, as they explore:
Report Clinical Studies Pharmaceutical Research and Development


MITIGATING SUPPLY CHAIN RISK IN AN AGE OF DISRUPTION

Don’t miss expert insights on:
On-Demand Webinar Clinical Studies Pharmaceutical Research and Development


TRANSFORMING NON-CLINICAL DEVELOPMENT WITH GLOBAL CRO PARTNERSHIPS

Discover expert perspectives on the drivers of non-clinical research and explore
how its common pain points can be overcome with the innovative approaches to
trial design and data collection offered by CROs. Download your free roundtable
report for key takeaways on:
Report Clinical Studies Pharmaceutical Research and Development


A JOURNEY FOR CONTINUOUS IMPROVEMENT THROUGH THE VOLUNTARY IMPROVEMENT PROGRAM

Innovize's VP of Quality shares insights on their participation in the Voluntary
Improvement Program (VIP) and how it facilitated their continuous organizational
improvement journey. Access valuable knowledge from their experience
volunteering as a Proof of Concept site, and key learnings on:
Case Study Clinical Studies Pharmaceutical Research and Development


MEETING REGULATION REQUIREMENTS WITH RTU CONTAINERS

Explore Annex 1, the latest update to the EU’s good manufacturing practice (GMP)
for medicinal products and discover its impact on the entire sterile medicine
production supply chain. Learn how service and packaging suppliers are
supporting pharmaceutical companies in de-risking their operations throughout
the process, in this data- and insight-packed white paper. Read now to:
Whitepaper Clinical Studies Pharmaceutical Research and Development


HOW IT WORKS

RavenConnects is a free-to-access digital library and content subscription
service designed for professional use with a wide-ranging library of
whitepapers, e-books, case studies, guides, and articles.

You can make use of our search function and topic filtering to find relevant
content quickly and easily. Our preference center puts you in control of your
contact and content preferences for RavenConnects and our sister publications.

All our content is free to access and share, in exchange, we ask that we have
your permission to disclose your professional details with the authors or
content providers. At the bottom of this page you can find links to our
jargon-free information on how we operate, and the data we process.

We will occasionally send you emails sharing content we believe is relevant to
your role and company. You can control how we communicate with you using the
Update Your Preferences link.

 * About Us
 * Contact Us

 * Update Your Preferences
 * Privacy Notice
 * © 2024 Berne UK LTD All Rights Reserved